Why are drugs more profitable than vaccines?
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2003
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
9833 |
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023590370 | ||
| 003 | DE-604 | ||
| 005 | 20090720 | ||
| 007 | t | ||
| 008 | 021128s2003 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)52861493 | ||
| 035 | |a (DE-599)BVBBV023590370 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a HB1 | |
| 082 | 0 | |a 330.072 | |
| 100 | 1 | |a Kremer, Michael |d 1964- |e Verfasser |0 (DE-588)128650532 |4 aut | |
| 245 | 1 | 0 | |a Why are drugs more profitable than vaccines? |c Michael Kremer ; Christopher M. Snyder |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2003 | |
| 300 | |a 36, [3] S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9833 | |
| 650 | 4 | |a Drug Industry |x economics | |
| 650 | 4 | |a Drugs | |
| 650 | 4 | |a Models, Econometric | |
| 650 | 4 | |a Pharmaceutical Preparations |x economics | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Vaccines |x economics | |
| 700 | 1 | |a Snyder, Christopher M. |e Verfasser |0 (DE-588)128651539 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9833 |w (DE-604)BV002801238 |9 9833 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w9833.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016905700 | ||
Datensatz im Suchindex
| _version_ | 1804138246351880192 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Kremer, Michael 1964- Snyder, Christopher M. |
| author_GND | (DE-588)128650532 (DE-588)128651539 |
| author_facet | Kremer, Michael 1964- Snyder, Christopher M. |
| author_role | aut aut |
| author_sort | Kremer, Michael 1964- |
| author_variant | m k mk c m s cm cms |
| building | Verbundindex |
| bvnumber | BV023590370 |
| callnumber-first | H - Social Science |
| callnumber-label | HB1 |
| callnumber-raw | HB1 |
| callnumber-search | HB1 |
| callnumber-sort | HB 11 |
| callnumber-subject | HB - Economic Theory and Demography |
| ctrlnum | (OCoLC)52861493 (DE-599)BVBBV023590370 |
| dewey-full | 330.072 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 330 - Economics |
| dewey-raw | 330.072 |
| dewey-search | 330.072 |
| dewey-sort | 3330.072 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01478nam a2200409zcb4500</leader><controlfield tag="001">BV023590370</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090720 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">021128s2003 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)52861493</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023590370</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">330.072</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kremer, Michael</subfield><subfield code="d">1964-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128650532</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Why are drugs more profitable than vaccines?</subfield><subfield code="c">Michael Kremer ; Christopher M. Snyder</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36, [3] S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9833</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Econometric</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">economics</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Snyder, Christopher M.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128651539</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9833</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">9833</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w9833.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016905700</subfield></datafield></record></collection> |
| id | DE-604.BV023590370 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:26Z |
| indexdate | 2024-07-09T21:25:08Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016905700 |
| oclc_num | 52861493 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 36, [3] S. graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Kremer, Michael 1964- Verfasser (DE-588)128650532 aut Why are drugs more profitable than vaccines? Michael Kremer ; Christopher M. Snyder Cambridge, Mass. National Bureau of Economic Research 2003 36, [3] S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9833 Drug Industry economics Drugs Models, Econometric Pharmaceutical Preparations economics Vaccines Vaccines economics Snyder, Christopher M. Verfasser (DE-588)128651539 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9833 (DE-604)BV002801238 9833 http://papers.nber.org/papers/w9833.pdf kostenfrei Volltext |
| spellingShingle | Kremer, Michael 1964- Snyder, Christopher M. Why are drugs more profitable than vaccines? National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Drug Industry economics Drugs Models, Econometric Pharmaceutical Preparations economics Vaccines Vaccines economics |
| title | Why are drugs more profitable than vaccines? |
| title_auth | Why are drugs more profitable than vaccines? |
| title_exact_search | Why are drugs more profitable than vaccines? |
| title_exact_search_txtP | Why are drugs more profitable than vaccines? |
| title_full | Why are drugs more profitable than vaccines? Michael Kremer ; Christopher M. Snyder |
| title_fullStr | Why are drugs more profitable than vaccines? Michael Kremer ; Christopher M. Snyder |
| title_full_unstemmed | Why are drugs more profitable than vaccines? Michael Kremer ; Christopher M. Snyder |
| title_short | Why are drugs more profitable than vaccines? |
| title_sort | why are drugs more profitable than vaccines |
| topic | Drug Industry economics Drugs Models, Econometric Pharmaceutical Preparations economics Vaccines Vaccines economics |
| topic_facet | Drug Industry economics Drugs Models, Econometric Pharmaceutical Preparations economics Vaccines Vaccines economics |
| url | http://papers.nber.org/papers/w9833.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT kremermichael whyaredrugsmoreprofitablethanvaccines AT snyderchristopherm whyaredrugsmoreprofitablethanvaccines |